Abstract
Increased morbidity and mortality from lower respiratory tract infection (LRTI) has been suggested in perinatal HIV-exposed uninfected (HEU) children; however, the contribution of respiratory viruses to this has not been defined.
What This Study Adds:
HEU infants had increased risk of LRTI hospitalization than HIV-unexposed uninfected infants, including specifically due to respiratory syncytial virus and human metapneumovirus infection. HEU infants overall, and infants with respiratory syncytial virus infection, had greater odds of death than HIV-unexposed uninfected.
Lower respiratory tract infections (LRTI) are a common cause of death in children aged <1 year, globally and in South Africa. 1, 2 Several studies have documented increased burden and severity of acute LRTI in HIV-infected children compared with HIV-uninfected children. [3] [4] [5] A few studies have reported LRTI to be more common and severe in HIV-exposed but uninfected (HEU) children compared with HIV-unexposed but uninfected (HUU) children; however, there are no data on viral cause-specific incidence of severe LRTI in these children. [6] [7] [8] [9] In addition, findings have not been consistent, and 1 study reported similar rates of LRTI in HEU and HUU children. 10 Similarly, several studies have reported increased mortality rates in HEU infants, whereas others have not found this association. 7, [11] [12] [13] [14] Factors shown to be predictive of mortality in HEU children include malnutrition, clinically diagnosed Pneumocystis jirovecii pneumonia or very severe pneumonia, severe anemia, not breastfeeding, and advanced maternal HIV. 7, 10, 15, 16 The recent expansion of access to strategies for the prevention of mother to child transmission of HIV (PMTCT) has led to marked reductions in HIV acquisition among children born to HIV-infected women, including in South Africa (2.7% in 2011) 17 ; however, the prevalence of HIV among pregnant women and consequently in utero HIV exposure of fetuses, has remained unchanged (30% in 2011). 17, 18 We aimed to compare the incidence of hospitalization for LRTI, overall and by viral etiology, in HUU, HEU, and HIV-infected infants aged <6 months using data from sentinel surveillance in South Africa. In addition, we aimed to compare the epidemiologic and clinical characteristics of HUU, HEU, and HIV-infected infants and assess whether HEU infants are at increased risk of mortality compared with HUU infants.
Description of the Surveillance Program
We included data collected from January 2010 through December 2013 from active, prospective, hospital-based surveillance (the Severe Acute Respiratory Illness [SARI] Program) in 3 of the 9 provinces of South Africa (Chris Hani-Baragwanath Academic Hospital [CHBAH] in an urban area of Gauteng Province, Edendale Hospital in a periurban area of KwaZulu-Natal Province, and Matikwana and Mapulaneng Hospitals in a rural area of Mpumalanga Province). In June 2010, an additional surveillance site was introduced at Klerksdorp Hospital in a periurban area of the North West Province. 19 
Case Definition
A case of hospitalized LRTI was defined as a hospitalized infant with ≤7 days' symptom duration meeting age-appropriate clinical case definitions (aged 2 days through <3 months of age with physician-diagnosed sepsis or LRTI or aged 3 to <6 months with physiciandiagnosis of bronchitis, bronchiolitis, pneumonia, and/or pleural effusion). We included infants aged <3 months with physician-diagnosed sepsis because LRTI could present nonspecifically in this age group.
Study Procedures
All patients admitted from Monday through Friday were eligible for enrollment. The total number of infants admitted meeting study case definitions and numbers enrolled were documented for the entire study period. In 2013, at CHBAH, enrollment of patients was limited to systematically varying 2 of every 5 working days because of high patient numbers and limited resources. Study staff completed case report forms until discharge and collected nasopharyngeal aspirates and blood specimens. All decisions on medical care, including mechanical ventilation and testing for Mycobacterium tuberculosis, were undertaken at the discretion of the attending physician. Data in case report forms were reviewed regularly to identify inconsistencies, and regular site visits were conducted to ensure adherence to study procedures.
Evaluation of HIV infection and exposure status
The determination of HIV infection and exposure status used information from testing undertaken as part of standard of care during the current admission 20 and through anonymized linked dried blood spot specimen testing by HIV polymerase chain reaction (PCR) as part of surveillance. HUU infants were defined as infants with a negative HIV PCR result on admission and a documented or reported negative maternal HIV status. HEU infants were defined as infants with a negative HIV PCR result on admission and a documented or reported positive maternal HIV status. HIV-infected infants were defined as infants with a positive HIV PCR result and CD4+ T-cell counts were determined by flow cytometry as part of standard of care. 21 Maternal breastfeeding was not considered in assessment of HIV infection status because PCR results at the time of admission in infants aged <6 months are likely to reflect current infant HIV status irrespective of whether infection was acquired at birth or through breastfeeding. Definitions for other underlying conditions are provided in the Methods section of the Supplemental Information.
Laboratory Methods
For additional details, please see the Supplemental Information.
Nasopharyngeal aspirates were immersed in universal transport medium at 4° to 8°C and transported to the National Institute for Communicable Diseases within 72 hours of collection. Specimens were tested by multiplex real-time reverse-transcription PCR for 10 respiratory viruses including influenza A and B viruses, parainfluenza virus types 1, 2, and 3; respiratory syncytial virus (RSV); enterovirus; human metapneumovirus (hMPV); adenovirus; and human rhinovirus. 22 Streptococcus pneumoniae was identified by quantitative real-time PCR detecting the lytA gene from whole blood specimens.
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Estimation of Incidence
Incidence estimates were calculated for Soweto (CHBAH) because population denominators were available for this site. This hospital is the only public hospital serving a community of ∼12 000 infants aged <6 months in 2012 among whom <10% have private medical insurance. 24 Consequently, the majority of individuals requiring hospitalization from this community are admitted to CHBAH. We estimated the incidence of hospitalization stratified by HIV infection and exposure status for the years 2010 and 2011 because data on HIV prevalence in pregnant women and rates of MTCT were only available for these years. 17, 25 We assumed that the HIV exposure and infection status among infants with unknown status was similar to those with known status. We calculated the annual incidence of LRTI hospitalization for infants <6 months of age per 100 000 individuals, by HIV exposure and infection status, by dividing the number of enrolled SARI cases each year (adjusted for nonenrollment on weekends and through refusal) in each category (HUU, HEU, and HIVinfected) by midyear population estimates for each group, multiplied by 100 000. We obtained estimates of the numbers of infants in the population in each HIV exposure group using population denominators for infants aged <1 year from the 2011 census for Region D (Soweto) and dividing these by 2. We then applied published data on HIV prevalence in pregnant women and rates of MTCT from the 2011 National South African PMTCT survey for Gauteng Province, where Soweto is located. 25, 26 Etiology-specific numbers were estimated by multiplying the adjusted numbers of SARI cases by the age-and HIV exposure statusspecific detection rates for each pathogen. We calculated the relative risk of SARI and etiology-specific hospitalization comparing HUU to HEU and HIV-infected infants. Confidence intervals (CIs) were calculated by using the Poisson distribution for incidence rates (IRs) and log binomial model for incidence rate ratios (IRRs).
Factors Associated With HIV Exposure Status and Death
For the analysis of factors associated with HIV-exposure status and death we included infants from any surveillance site from 2010 through 2013 with known HIV exposure status and in-hospital outcome. We implemented 2 multivariable models to identify factors associated with 2 outcome variables: (1) HIV infection/exposure status and (2) mortality. Multinomial regression was used for the comparison of factors associated with HIV infection/exposure. Multinomial regression allows modeling of outcome variables with >2 categories and relates the probability of being in category j to the probability of being in a baseline category. A complete set of coefficients was estimated for each of the j levels being compared with the baseline, and the effect of each predictor in the model was measured as relative risk ratio (RRR). For this analysis, HUU infants were used as the referent group and compared with HEU and HIV-infected infants. The model to assess factors associated with mortality was implemented using logistic regression. For both models, we assessed all variables that were significant at P < .2 on univariate analysis and dropped nonsignificant factors (P ≥ .05) with stepwise backward selection. Patients with missing data for included variables were dropped from the model. In addition, for the mortality analysis, we excluded variables considered to be on the causal pathway for mortality (eg, length of hospital stay, ICU admission). The statistical analysis was implemented using Stata version 12 (StataCorp Inc, College Station, TX). We conducted a sensitivity analysis of the association between HIV exposure and infection status and mortality restricted to individuals with documented maternal HIV status and a separate analysis excluding infants with suspected sepsis. Results of these analyses are reported in the Supplemental Information.
Results
Characteristics of Enrolled Infants
From January 2010 through December 2013, 3537 infants aged <6 months fulfilling the LRTI case definition were enrolled (Fig 1) Only 7% (196/2391) of infants had an underlying medical condition other than HIV infection, the commonest of which was premature birth (n = 164). Among infants with available data, 22% (170/773) were malnourished, the overall case fatality ratio was 3% (71/2488), and 2% (55/2493) were admitted to the ICU. Tuberculosis testing was performed on 372 (15%) children, from whom M tuberculosis was identified in 37 (10%) cases (18/195 in HIV-infected, P < .001). Supplemental oxygen was administered to 47% (1160/2493) of enrolled infants. The percentage of infants aged >6 weeks who had received age-appropriate doses of pneumococcal conjugate vaccine was 76% (1113/1455). Information on receipt of antiretroviral treatment (ART) was only available for 48 of 211 (23%) HIV-infected infants, and 16 (33%) had reported receipt of ART. CD4+ T-cell count was only available for 56 (27%) of HIV-infected infants, and 82% (n = 46) had CD4+ T lymphocytes <25%. 27 
Incidence of Hospitalization in HUU, HEU, and HIV-Infected Infants in Soweto
The annual incidence (per 100 000 population) of LRTI hospitalization among infants <6 months of age in Soweto was lowest in HUU infants (10 404; 95% CI 9947-10 877), and 1.4-fold higher in HEU (14 288; 95% CI 13 437-15 178; IRR 1.4; 95% CI 1.3-1.5) and 3.7-fold greater among HIV-infected infants (38 445; 95% CI 33 080-44 438; IRR 3.7; 95% CI 3.2-4; Table 1 ). Among viruses with high likelihood of etiologic attribution, RSV-associated (IRR 1.4; 95% CI 1.3-1.5), hMPV-associated (IRR 1.4; 95% CI 1.1-2.0), and influenza-associated (IRR 1.2; 95% CI 0.8-1.8) LRTI point estimates of incidence were higher in HEU relative to HUU infants, although this was not statistically significant for influenza (for which there was the lowest number of cases, n = 56). For other viruses, estimates were generally similar, although numbers were small in some groups ( Table 1) . 
Characteristics of HUU, HEU, and HIV-Infected Infants
Compared with HUU on multivariable analysis, and controlling for hospital, race, and year of admission, HEU infants were more likely to be hospitalized for 2 to 7 days (adjusted relative risk ratio [aRRR] 1.5; 95% CI 1.3-1.9) or >7 days (aRRR 1.8; 95% CI 1.4-2.4) compared with <2 days; to require mechanical ventilation (aRRR 2.3; 95% CI 1.1-5.0); and to die in-hospital (aRRR 2.1; 95% CI 1.1-3.9; Supplemental Table 4 ).
Compared with HUU on multivariable analysis controlling for hospital, age, and year, HIVinfected infants were less likely to test positive for RSV (aRRR 0.3; 95% CI 0.2-0.04); however, HIV-infected infants were more likely to be hospitalized for >7 days (aRRR 5.6; 95% CI 3.1-10.0) compared with <2 days, to require oxygen (aRRR 2.0; 95% CI 1.3-2.9) or ventilation (aRRR 2.9; 95% CI 1.1-7.7), and to die in-hospital (aRRR 6.3; 95% CI 3.1-13.1; Supplemental Table 4 ).
Factors Associated With In-Hospital Mortality
On multivariable analysis, HEU had 2 times (adjusted odds ratio [aOR] 2.1; 95% CI 1.1-4.5), and HIV-infected 5 times (aOR 5.3; 95% CI 2.4-11.8), greater odds of in-hospital mortality compared with HUU infants. PCR detection of pneumococcus in blood was associated with increased mortality (aOR 4.8; 95% CI 1.8-12.7), and detection of any virus (vs no virus detected) was associated with decreased mortality (aOR 0.5; 95% CI 0.2-0.9; Table 2 ). Mortality was substantially higher at Matikwana/Mapulaneng Hospitals (aOR 17.2; 95% CI 7.0-45.0) compared with CHBAH. When stratified by etiology, for most pathogens, case fatality ratios were elevated in HEU and HIV-infected individuals compared with HIVuninfected individuals, although numbers of cases and deaths were low in some subgroups (Table 3) . Case fatality ratios were significantly elevated for HEU infants with RSV compared with HUU infants. 
Discussion
As a result of the widespread implementation of interventions for PMTCT in South Africa, the numbers of HIV-infected infants continue to decline, 17 while the number of HEU infants remains high. We have shown that HEU infants aged <6 months experienced elevated incidence of LRTI hospitalization when compared with HUU infants in Soweto, South Africa. When stratified by etiology, among pathogens with a high etiologic fraction, this association was specifically observed for RSV and hMPV. In addition, once hospitalized, HEU infants were more likely to have a prolonged hospitalization and to die in-hospital compared with HUU infants, highlighting the need for this group to be considered an at-risk group for severe pneumonia.
National guidelines revised in 2013 recommend the initiation of ART in all HIV-infected infants aged <6 months. 28 Access to ART for HIV-infected infants has increased in recent years, with an estimated pediatric ART coverage of 63% in South Africa in 2013. 29 Despite this reported increased coverage of ART, in our study, HIV-infected infants experienced a 4 times greater risk of hospitalization and 3 times greater in-hospital mortality compared with HUU infants. Estimates of the relative risk of hospitalization are slightly greater than previous estimates for infants aged <12 months from the same study site comparing HIVinfected to HIV-uninfected infants irrespective of HIV exposure status. 3 The slightly higher relative risk is to be expected when comparing to a baseline of only HUU as the composite incidence of HEU and HUU together would be somewhat elevated due to the higher incidence in the HEU group. RSV was identified less frequently in HIV-infected than HEU infants, although the incidence of hospitalization for RSV-associated LRTI was greater (although not statistically significantly so) in HIV-infected infants. This is likely because of the proportionately greater contribution of opportunistic pathogens such as Pneumocystis jirovecii and Mycobacterium tuberculosis to LRTI in HIV-infected infants, as has been described previously. 3, 30, 31 We collected results of clinician testing for tuberculosis and clinician initiation of tuberculosis treatment and evaluated this in multivariate models; however, laboratory confirmation of tuberculosis in young infants may be difficult because disease is often paucibacilliary. 32 We found a 1.4 times increased incidence of LRTI hospitalization in HEU compared with HUU infants, which was similar to the 1-to 2-fold increased risk of all-cause and LRTI hospitalization in HEU compared with HUU infants reported by others. 8, 33 Our estimate likely represents a minimum estimate because we relied on maternal history of HIV infection status to determine HIV exposure status. It is possible that some HIV-infected women may have falsely reported their HIV status as HIV uninfected, whereas the converse is unlikely to have occurred. This may have led to some misclassification of HIV exposure status with some HEU infants included in the HUU group, with consequent underestimation of the relative risk of hospitalization in HEU.
In our study, compared with HUU infants, HEU infants hospitalized with LRTI were twice as likely to die in hospital, had longer hospital stays and were more likely to receive mechanical ventilation. Published cohort studies have found that HEU have 2 to 4 times greater risk of all-cause death compared with HUU infants. 7, 34, 35 Furthermore, infants testing positive for pneumococcus were 5 times more likely to die. This association with more severe outcomes for pneumococcus-associated pneumonia has been previously demonstrated. 3 Studies have found whole blood lytA PCR to be specific for pneumococcal pneumonia in young infants; however, positive results may reflect occult bacteremia in some infants. [36] [37] [38] Patients with any respiratory viral infection were also less likely to die. Respiratory viral pneumonia has been associated with lower case-fatality ratios compared with bacterial pneumonia in previous studies. 3 A substantially higher mortality was identified at the Agincourt surveillance site compared with CHBAH. This site is the only rural site included in the surveillance, and worse outcome may relate to delays in access to care or increased burden of underlying illness or poorer quality of care, but data to support these hypotheses are not available.
There are few published data on the relative risk of LRTI hospitalization for specific etiologies in HEU infants. 39 Point estimates of relative risk for hospitalization in HEU compared with HUU infants for all 3 viruses with a high etiologic fraction that were evaluated (RSV, hMPV, and influenza) were similar to the overall estimate for LRTI, although the incidence was not statistically significantly elevated for influenza, possibly because of the small numbers of cases of influenza included. 40 A nationwide study from South Africa found that HEU patients aged <6 months had 3 to 4 times increased incidence of invasive pneumococcal disease, compared with HUU infants. 39 Bacterial coinfection may have contributed to some of the observed increase in hospitalization and in-hospital mortality in patients with confirmed viral infection; however, the numbers of patients testing lytApositive with available HIV infection and exposure information (n = 16) were too few to explore this hypothesis or make any firm conclusions about pneumococcal epidemiology in HUU. Interpretation of incidence and case-fatality ratios for viruses with a low etiologic fraction is challenging. 40 Studies have shown an elevated mortality in HEU infants aged <6 months. 7 This elevated mortality as well as the observed increased risks of hospitalization in our study may be the result of immunologic deficits that have been documented in HEU infants. [41] [42] [43] [44] The degree of maternal immunosuppression has been shown to be an important predictor of infant survival, and ART use in pregnancy may have an impact on infant birth weight and immune response, but we did not have data on maternal CD4+ T-cell count or use of ART during pregnancy in our study to assess this association. 45, 46 Other possible reasons for the increased risk of severe outcomes observed in HEU infants include possible increased exposure to maternally derived pathogens including cytomegalovirus, reduced transfer of protective antibodies from severely immunosuppressed mothers, and possible impaired responses to some vaccines. 46 Our study had several limitations. HIV exposure status was only available for 70% of infants, which could have led to bias if the characteristics of infants with available data differed from those without available data. We did not collect data on breastfeeding, which is an important predictor of mortality in the first 6 months of life. 47 Other unmeasured confounders such as patient socioeconomic status could have confounded the associations observed. Patients who die may be less likely to be enrolled, which could lead to underestimation of mortality. 48 We were only able to estimate incidence from 1 large urban site for 2 of the study years, which may limit the generalizability of our findings to other settings in South Africa. Low case numbers may have reduced our power to detect differences in incidence for certain pathogens. Additional uncertainty may have been introduced through adjustment for nonenrollment, and this was not included in the estimation of confidence intervals. We obtained denominators in infants aged <6 months by dividing published numbers aged <1 year by 2. This may have introduced bias because mortality may be higher in the first 6 months of life.
Conclusions
We have described a higher incidence of hospitalization and worse in-hospital outcomes for HEU infants and HIV-infected infants aged <6 months compared with HUU infants. Almost 30% of infants born in South Africa each year are HEU, and this group might benefit from interventions to reduce the burden of LRTI, including access to pneumococcal conjugate vaccine, which has been shown to be effective for HEU infants. 17, 49 In addition, ongoing access to PMTCT for HIV-infected pregnant women and improved access to ART for HIVinfected infants is important to reduce the LRTI burden in HIV-infected infants. 
Supplemental Information
LABORATORY METHODS
Because of challenges with availability of reagents, we did not test for adenovirus from August to October 2009.
Specimens for Mycobacterium tuberculosis identification were examined by light microscopy for the presence of acid-fast bacilli and culture was performed using the BACTEC MGIT automated culture system (Becton Dickinson, Franklin Lakes, NJ).
DEFINITIONS FOR OTHER UNDERLYING CONDITIONS
Underlying conditions included premature birth (gestational age <37 weeks), chronic lung disease, chronic heart disease, liver disease, renal disease, immunocompromising conditions excluding HIV infection, or neurologic disease. Infants with weight-for-age z scores less than -2 using the 2009 World Health Organization child growth standards were classified as being malnourished. 50 Data on weight were only systematically available from 2011 onward when this question was introduced. Comorbidities were considered absent in cases for which the medical records stated that the patient had no underlying medical condition or when there was no direct reference to that condition.
REPORTING OF RESULTS
For the reported analysis of incidence rates and factors associated with in-hospital death stratified by virus detected, we focused on tested viruses for which the etiologic fraction (proportion of LRTI cases in individuals testing positive for a pathogen thought to be attributable to the pathogen) in infants <5 years is >90% (influenza, RSV, and hMPV) on the basis of previous studies from South Africa. 41 These studies compared the prevalence of detection of respiratory viruses at 2 of the SARI surveillance sites to age-and HIV-statusmatched controls. The reason for focusing on pathogens with high etiologic fraction is because interpretation of incidence rates is unclear for pathogens with a low likelihood of etiologic attribution. The results for the additional tested viruses are, however, included in the tables.
SUPPLEMENTAL RESULTS
Detection Rates by HIV Exposure and Infection Status
The detection rate of all pathogens evaluated was similar in HUU, HEU, and HIV-infected infants except for RSV, which was identified at a lesser proportion in HIV-infected infants (Supplemental Table 4 ).
Comparison of HIV-Uninfected Infants With Self-Reported Versus Documented Maternal HIV Status
Infants with self-reported maternal HIV status did not differ from infants with documented maternal HIV status with regard to age, gender, or race. Source of maternal HIV status did vary by hospital with only 5% (128/2232) of maternal HIV status at CHBAH from medical records (vs maternal verbal report) compared with 52% (228/440) at Matikwana/Mapulaneng, 42% (236/558) at Edendale and 51% (128/253) at KTHC (P < .001). In addition, the proportion of results based on medical records increased each year from 6% (48/814) in 2009% to 65% (397/610) in 2013 (P < .001).
Sensitivity Analysis Restricted to Individuals With Documented Maternal HIV Status
On sensitivity analysis of the association between HIV exposure and infection status and mortality restricted to individuals with maternal HIV status from medical records, CFR was increased in HEU and HIV-infected compared with HUU overall (CFR for HUU 3% [8/248] 
Comparison of Infants With a Diagnosis of Physician-Diagnosed Sepsis to Infants Without Physician-Diagnosed Sepsis
Among 2507 enrolled infants 12% (n = 306) had a diagnosis of physician-diagnosed sepsis. A diagnosis of physician-diagnosed sepsis was more common in infants aged ≤28 days (60%, 345/573) than >28 days (5%, 156/2964 P < .001). Infants with physician-diagnosed sepsis has a similar gender and race distribution to those without suspected sepsis and the CFR was similar in infants with physician-diagnosed sepsis (2%, 8/498) to those without suspected sepsis (3%, 87/3006). The proportion of infants with a diagnosis of physiciandiagnosed sepsis was similar in HUU (13%, 186/1446) and HEU (13%, 112/850) but lower in HIV-infected infants (4%, 8/306 P < .001).
Sensitivity Analysis Excluding Infants With a Diagnosis of Physician-Diagnosed Sepsis
On sensitivity analysis excluding infants with a diagnosis of physician-diagnosed sepsis, the trend toward increased mortality in HEU and HIV-infected compared with HUU infants remained; however, this was not statistically significant when comparing HEU to HUU (data not shown). Similarly, the trend toward increased incidence in HEU and HIV-infected infants remained excluding infants with a diagnosis of physician-diagnosed sepsis and remained statistically significant overall and by viral infections for the more common pathogens (data not shown). Differences were not consistently statistically significant for pathogens with <100 positive cases. Interpretation of the RRRs is as follows: for a unit change in the predictor variable, the RRR of outcome of interest (in this case, either HEU or HIV infected) relative to the referent group (HIV unexposed) is expected to change by a factor of the respective parameter estimate given the variables in the model are held constant. PCV, pneumococcal conjugate vaccine. a Variables were retained in the multinomial multivariable model if they were signifi cant at P < .05 for either the HUU for HIV-infected group using with stepwise backward selection. 
SUPPLEMENTAL
